Acquisitions24 Apr 2025, 09:07 pm
Bharat Parenterals Successfully Acquires Varenyam Healthcare, Boosting Revenue and EBITDA
AI Summary
Bharat Parenterals Limited has completed the acquisition of Varenyam Healthcare Pvt. Ltd., making it a wholly owned subsidiary. The transaction was executed through a share swap, involving the issuance of 351,255 equity shares of BPL on a preferential basis in exchange for 2,50,000 equity shares of VHPL. VHPL is a domestic leader in the marketing of high-quality pharmaceutical formulations across Anesthesia, Critical care and Pain management segments. For FY2025-26, VHPL is expected to contribute approximately ₹60 crores in revenue and ₹10 crores in EBITDA. This acquisition concludes the strategic corporate restructuring initiative first announced on June 5, 2024.
Key Highlights
- Bharat Parenterals has successfully acquired Varenyam Healthcare Pvt. Ltd.
- VHPL is a domestic leader in the marketing of high-quality pharmaceutical formulations across Anesthesia, Critical care and Pain management segments.
- VHPL is expected to contribute approximately ₹60 crores in revenue and ₹10 crores in EBITDA for FY2025-26.
- This acquisition concludes the strategic corporate restructuring initiative first announced on June 5, 2024.
- The acquisition is designed to simplify the group structure, enhance operational control, and create synergistic value across BPL’s manufacturing and commercial platforms.